1.Mechanistic study of FOXK1 in promoting laryngeal squamous cell carcinoma progression by upregulating AKT2 expression
Xu Yuru1 ; Lu Guang2 ; Liu Meng1 ; Hu Guobin1 ; Liu Shenghui1 ; Zhao Ruili1 ; Lan Lili1
Chinese Journal of Cancer Biotherapy 2026;33(7):754-762
[摘 要] 目的:探讨叉头框K1(FOXK1)在喉鳞状细胞癌(LSCC)中的表达、临床意义及对细胞增殖、迁移、侵袭的影响,并阐明其分子机制。方法:RT-qPCR、免疫组化检测LSCC组织及LSCC细胞TU177中FOXK1表达,分析其与临床病理参数及预后的相关性;通过瞬时转染构建FOXK1过表达与敲低细胞模型,通过MTS法、克隆形成实验、划痕愈合实验和Transwell实验检测细胞恶性生物学行为的变化;采用RT-qPCR检测上皮-间充质转化(EMT)相关因子mRNA的表达;采用WB法检测PI3K/AKT信号通路相关蛋白的表达;结合生物信息学预测与功能回复实验,验证FOXK1对AKT2的调控作用。结果:FOXK1在LSCC组织及细胞中高表达(P < 0.01),且主要定位于细胞核;FOXK1高表达与较晚TNM分期相关(P < 0.05),且FOXK1高表达患者5年生存率较低(P < 0.05);过表达FOXK1显著增强TU177细胞增殖、迁移与侵袭能力并诱导EMT(P < 0.01或P < 0.05),敲低FOXK1则产生相反的效应;FOXK1可上调AKT2表达并激活PI3K/AKT信号通路;敲低AKT2可部分逆转FOXK1过表达对细胞增殖、迁移、侵袭及EMT进程的促进作用(P < 0.01或P < 0.05)。结论:FOXK1在LSCC中高表达,与肿瘤进展及不良预后密切相关。FOXK1可能通过上调AKT2激活PI3K/AKT信号通路,诱导EMT,从而促进LSCC细胞的恶性生物学行为。
2.Transcription factor HOXC13 promotes malignant biological behaviors of laryngeal squamous cell carcinoma by upregulating PCNA expression
LAN Lili1 ; NIU Yunfeng2 ; HU Guobin1 ; LIU Meng1 ; XU Yuru1 ; WANG Jingtian1
Chinese Journal of Cancer Biotherapy 2024;31(6):558-565
[摘 要] 目的:本研究旨在探讨转录因子HOXC13在喉鳞状细胞癌(LSCC)中的表达、功能及可能的调控机制。方法:常规培养LSCC细胞,将其分为sh-NC组、sh-HOXC13组、pcDNA3.1-NC组、pcDNA3.1-HOXC13组、pcDNA3.1-PCNA组和sh-HOXC13+pcDNA3.1-PCNA组,用转染试剂将相应核酸和质粒转染各组细胞。用数据库数据分析HOXC13 mRNA在LSCC组织中的表达;收集2019年1月至2022年12月在联勤保障部队第九八〇医院耳鼻咽喉头颈外科手术切除的62对LSCC组织及配对的癌旁组织,免疫组织化学法检测中国人LSCC组织中HOXC13蛋白的表达,qPCR检测中国人LSCC组织、癌旁组织以及各组细胞中HOXC13和PCNA mRNA的表达,MTS法检测各组AMC-HN-8细胞的增殖能力,平板克隆实验检测各组AMC-HN-8细胞的克隆形成能力,Transwell小室实验检测各组AMC-HN-8细胞的迁移和侵袭能力,双萤光素酶报告基因实验和染色质免疫沉淀技术(ChIP)验证HOXC13与PCNA之间的结合关系。结果:HOXC13和PCNA在LSCC组织和细胞中均呈高表达(P<0.05或P<0.01)且两者的表达水平呈正相关(P<0.01),HOXC13的表达水平与TNM分期有明显关联(P<0.01)。敲减HOXC13可明显抑制AMC-HN-8细胞的增殖、迁移和侵袭能力(均P<0.01),过表达HOXC13则促进TU686细胞的增殖、迁移和侵袭能力(均P<0.01)。HOXC13可与PCNA启动子区结合并调控其转录。敲低PCNA可部分逆转HOXC13对AMC-HN-8细胞的恶性生物学行为的促进作用(均P<0.01)。结论:HOXC13通过上调PCNA促进LSCC细胞的恶性生物学行为,HOXC13是LSSC临床诊断和治疗的潜在靶点。
3.Effect of Mir-127-3p on Proliferation,Apoptosis,Migration and Invasion of Uveal Melanoma Cells via Targeting MAPK4
Li1 WEI ; Hong-mei2 LIAN ; Peng1 LIU ; Xinghua1 LIU ; Shu-yi3 WU ; Meng-meng1 LIU
Journal of Sun Yat-sen University(Medical Sciences) 2020;41(1):76-85
【Objective】To investigate the effect of miR- 127-3p on proliferation,apoptosis,migration and invasion of uveal melanoma cells.【Methods】The expression of miR- 127- 3p and MAPK4 mRNA in human uveal melanoma tissues and cells,normal tissues and cells were detected by RT-qPCR. The mimic-NC,miR-127-3p mimic,pc-MAPK4 plasmids were transfected into SP6.5 or OM431 cells,respectively,by Lipofectamine 2000. The relationship between miR-127-3p and MAPK4 counterstaining was detected by dual luciferase assay. Cell proliferation was detected by CCK- 8 method,apoptosis was detected by flow cytometry,cell migration ability was detected by scratch test,cell invasion ability was detected by Transwell method,and relative expression level of AKT/mTOR pathway protein was detected by Western blot.【Results】In uveal melanoma tissues and cell lines,the expression of miR- 127-3p was down-regulated(P < 0.01)while that of MAPK4 expression was significantly up-regulated(P < 0.01). The binding site of miR-127-3p and MAPK4 3′UTR region,the high expression of miR-127-3p significantly inhibited the luciferase activity of wild-type MAPK4 plasmid(P < 0.01),but the mutant MAPK4 plasmid Luciferase activity has no effect. Compared with the Control group ,the proliferation of SP6.5 cells and OM431 cells in miR- 127-3p mimic group were significantly decreased(P < 0.01),and the apoptotic rate was significantly increased(P < 0.01). The scratch closure rate was obvious. The decrease(P < 0.01), the number of invading cells per field was significantly decreased(P < 0.01),and the expression of p-AKT(T308)/AKT and p-mTORr(S473)/mTOR protein were significantly down-regulated(P < 0.01). Transfection of pc-MAPK4 reversed the above changes.【Conclusion】MiR-127-3p inhibits proliferation,migration and invasion of uveal melanoma cells and induces apoptosis by down-regulating MAPK4,which may be involved in the inhibition of AKT/mTOR pathway activation.

Result Analysis
Print
Save
E-mail